Phase 2b REZOLVE-AD Topline Results from 16-Week Induction Rezpegaldesleukin in Patients with Moderate-to- Severe Atopic Dermatitis June 24, 2025 1 Forward-Looking Statements Safe Harbor Statement This presentation and any accompanying oral discussion contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, express or implied statements regarding Nektar Therapeutics (the "Company" or "Nektar")'s plans, progress, and timing ...

Company Overview - Sally Beauty Holdings Inc has $3.7 billion in net sales[7] - The company's gross margin is 50.9%[7] - Adjusted EBITDA is $442 million[7] - Approximately 34% of sales are from owned brands[7] - Around 53% of sales are from brands under exclusive/limited distribution agreements[8] Financial Performance & Strategy - Fuel for Growth initiative delivered $28 million benefit in FY24 and is expected to deliver $40+ million benefit in FY25[39] - The company refinanced senior secured notes in February 2024, reducing principal from $680 million to $600 million and extending maturity to FY2032[52] - The company's long-term debt totals $994 million, with $394 million in term loans and $600 million in senior notes[49] - The company aims to increase Sally's owned brand penetration from 34% to over 50%[32]

Company Overview - Kinsale Capital Group, founded in 2009, focuses on the excess and surplus lines market in the United States[4] - The company's market capitalization was $96 billion as of September 30, 2023[4] - Kinsale's YTD combined ratio was 767% as of September 30, 2023[4] - The company's YTD annualized operating return on equity was 321% as of September 30, 2023[4] - Kinsale aims to expand its 1% market share[4] Underwriting Strategy - Kinsale focuses on small-to-medium sized, hard-to-place risks in the excess and surplus lines market[27, 28] - The company emphasizes individual risk underwriting and tailored coverage[31, 36] - Kinsale uses a technology-enabled, low-cost approach to manage expenses[32] - The company has underwriters specializing in various casualty, professional lines, specialty casualty, transportation, and property divisions[21] Market Position and Growth - Kinsale's underwriting performance, measured by the net loss and loss adjustment expense ratio, is compared against the P&C industry and surplus lines sector[13] - The company is focused on leveraging data for pricing, risk segmentation, and automation[170]

Business Model & Revenue - The company's business model drives strong free cash flow through recurring revenue, high renewal rates, and high contribution margins[6] - Total revenue in 2024 exceeded $6 billion, with research subscriptions accounting for 77% of the total[9] - Approximately 75% of research revenue contracts are multi-year agreements, averaging around 1.7 years in length[11] Retention Rates - Client retention rates have been consistently high, reaching 84.3% in 2024[15] - Wallet retention rate was 104% in 2024, indicating growth from existing clients[13] Profitability & Margins - The consolidated Gartner contribution margin was 67.7% in 2024[19] - The research segment contribution margin was 74% in 2024[21] Cash Flow & Investments - Cash provided by operating activities reached $1.485 billion in 2024[26] - Capex spending is expected to be approximately 2% of revenue[36] - The company is reinvesting for growth, with quota-bearing headcount (GTS & GBS) reaching 5,102 in 2024, representing a 7% CAGR[39] Financial Performance - EBITDA reached $1.556 billion in 2024, demonstrating a 17% CAGR[44] - Free cash flow was $1.383 billion in 2024, with a 14% CAGR[46]

ARCHROCK, INC. February 2024 Forward-Looking Statements All statements in this presentation (and oral statements made regarding the subjects of this presentation) other than historical facts are forward–looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward–looking statements rely on a number of assumptions concerning future events and are subject to a number of uncertainties and factors that could cause actual results to differ materially from ...

INVESTOR PRESENTATION APRIL2024 oilstatesintl.com Forward-looking Statements The following contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are those that do not state historical facts and are, therefore, inherently subject to risks and uncertainties. The forward-looking statements included herein are based on current expectations and entail various risks and uncertainties th ...

October 2024 Forward-Looking Statements Certain written statements in this presentation may contain, and members of management may from time to time make or discuss statements which constitute, "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, all matters that are not historical facts. Forward-looking statements are not assurances of future performance. Instead, t ...

Investor Presentation June 2025 Safe harbor statement Statements in this presentation regarding TD SYNNEX that are not historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward- looking statements are inherently uncertain, and stockholders and other potential investors must recognize that actual results may differ materially from TD SYNNEX expectations as a result of a variety of fact ...

Breakthrough Antibodies for Obesity and Cardiometabolic Diseases Investor Call June 24, 2025 Forward looking statements Certain statements in this presentation constitute "forward -looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 , as amended . Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, ...

Q4 2014 Results and 2015 Outlook Conference Call February 26, 2014 © 2015 Harsco Corporation. All rights reserved. Administrative Items Non-GAAP Measures Conference Call and Access to Information Throughout the Company's call and this presentation, the Company refers to certain non-GAAP measures, including, without limitation, adjusted operating income (loss) from continuing operations, adjusted operating income margin, adjusted diluted earnings per share from continuing operations, return on invested capit ...